Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Beutler

Showing results (161-170 of 271) with videos related to

Pageof 28
Sort By:
Nature Immunology|May 17, 2005
CD14 is required for MyD88-independent LPS signalingZhengfan Jiang, Philippe Georgel, Xin Du, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2021
Sulfatides are endogenous ligands for the TLR4-MD-2 complexLijing Su, Muhammad Athamna, Ying Wang, et al.
Journal of the American Chemical Society|October 2, 2018
Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor AgonistsMatthew D Morin, Ying Wang, Brian T Jones, et al.
Nature Communications|July 16, 2022
Loss of immunity-related GTPase GM4951 leads to nonalcoholic fatty liver disease without obesityZhao Zhang, Yu Xun, Shunxing Rong, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2014
Mutation of mouse Samd4 causes leanness, myopathy, uncoupled mitochondrial respiration, and dysregulated mTORC1 signalingZhe Chen, William Holland, John M Shelton, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2016
Insulin resistance and diabetes caused by genetic or diet-induced KBTBD2 deficiency in miceZhao Zhang, Emre Turer, Xiaohong Li, et al.
Journal of Medicinal Chemistry|March 5, 2019
Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist DiprovocimLijing Su, Ying Wang, Junmei Wang, et al.
European Journal of Immunology|March 1, 2006
R-form LPS, the master key to the activation ofTLR4/MD-2-positive cellsMichael Huber, Christoph Kalis, Simone Keck, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2025
Structural insights into the ubiquitin-independent midnolin-proteasome pathwayNagesh Peddada, Xue Zhong, Yan Yin, et al.
American Journal of Physiology. Renal Physiology|January 23, 2009
Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/TrifJulia Lichtnekert, Volker Vielhauer, Daniel Zecher, et al.
Pageof 28

Showing results (161-170 of 271) with videos related to

Sort By:
Pageof 28
Nature Immunology|May 17, 2005
CD14 is required for MyD88-independent LPS signalingZhengfan Jiang, Philippe Georgel, Xin Du, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2021
Sulfatides are endogenous ligands for the TLR4-MD-2 complexLijing Su, Muhammad Athamna, Ying Wang, et al.
Journal of the American Chemical Society|October 2, 2018
Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor AgonistsMatthew D Morin, Ying Wang, Brian T Jones, et al.
Nature Communications|July 16, 2022
Loss of immunity-related GTPase GM4951 leads to nonalcoholic fatty liver disease without obesityZhao Zhang, Yu Xun, Shunxing Rong, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2014
Mutation of mouse Samd4 causes leanness, myopathy, uncoupled mitochondrial respiration, and dysregulated mTORC1 signalingZhe Chen, William Holland, John M Shelton, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2016
Insulin resistance and diabetes caused by genetic or diet-induced KBTBD2 deficiency in miceZhao Zhang, Emre Turer, Xiaohong Li, et al.
Journal of Medicinal Chemistry|March 5, 2019
Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist DiprovocimLijing Su, Ying Wang, Junmei Wang, et al.
European Journal of Immunology|March 1, 2006
R-form LPS, the master key to the activation ofTLR4/MD-2-positive cellsMichael Huber, Christoph Kalis, Simone Keck, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2025
Structural insights into the ubiquitin-independent midnolin-proteasome pathwayNagesh Peddada, Xue Zhong, Yan Yin, et al.
American Journal of Physiology. Renal Physiology|January 23, 2009
Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/TrifJulia Lichtnekert, Volker Vielhauer, Daniel Zecher, et al.
Pageof 28